Verrica Pharmaceuticals, Inc. (VRCA) Q1 2025 Corporate Update Conference Call
Verrica Pharmaceuticals(US:VRCA) Seeking Alphaยท2025-05-13 22:33Group 1 - Verrica Pharmaceuticals held its Q1 2025 Corporate Update Conference Call on May 13, 2025, with key participants including the CEO, CFO, and COO [1][3] - The call included discussions on the commercialization of YCANTH for treating molluscum contagiosum in the U.S., revenue growth, regulatory developments, and the company's product candidates [4][5] - Management emphasized the importance of forward-looking statements regarding the company's business strategy and operations, highlighting potential risks and uncertainties [4][5]